Key Record Dates
ClinicalTrials.gov Identifier: | NCT04604132 |
---|---|
Brief Title: | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03) |
First Submitted : | October 21, 2020 |
First Submitted that Met QC Criteria : | October 21, 2020 |
First Posted : | October 27, 2020 |
Last Update Submitted that Met QC Criteria : | March 7, 2022 |
Last Update Posted : | March 8, 2022 |